5-151185521-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015621.3(CCDC69):āc.516G>Cā(p.Gln172His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,978 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015621.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC69 | NM_015621.3 | c.516G>C | p.Gln172His | missense_variant | 7/9 | ENST00000355417.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC69 | ENST00000355417.7 | c.516G>C | p.Gln172His | missense_variant | 7/9 | 1 | NM_015621.3 | P1 | |
CCDC69 | ENST00000521308.5 | n.563G>C | non_coding_transcript_exon_variant | 6/8 | 1 | ||||
CCDC69 | ENST00000518189.5 | c.471G>C | p.Gln157His | missense_variant, NMD_transcript_variant | 6/8 | 1 | |||
CCDC69 | ENST00000522964.1 | c.*113G>C | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251396Hom.: 1 AF XY: 0.0000442 AC XY: 6AN XY: 135858
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461750Hom.: 1 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 727190
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.516G>C (p.Q172H) alteration is located in exon 7 (coding exon 7) of the CCDC69 gene. This alteration results from a G to C substitution at nucleotide position 516, causing the glutamine (Q) at amino acid position 172 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at